Hypertrophic Cardiomyopathy: A Brief Overview

Area of Science:

• Cardiology
• Genetics
• Internal Medicine

Background:

• Hypertrophic cardiomyopathy (HCM) is a genetic heart muscle disease affecting approximately 1 in 500 individuals globally.
• It is characterized by unexplained left ventricular hypertrophy, often asymmetric, with myocyte disarray.
• Left ventricular outflow tract obstruction is present in about 60% of HCM patients.

Purpose of the Study:

• To summarize the key features and clinical spectrum of hypertrophic cardiomyopathy.
• To highlight the heterogeneity in cardiac morphology and natural history of HCM.
• To underscore the variable clinical presentation, from asymptomatic to severe heart failure or sudden death.

Main Methods:

• Review of existing literature and clinical data on hypertrophic cardiomyopathy.
• Analysis of epidemiological data regarding prevalence worldwide and in the US.
• Characterization of pathological hallmarks, including left ventricular hypertrophy and myocyte disarray.

Main Results:

• HCM affects an estimated 750,000 Americans and 1 in 500 worldwide.
• The disorder presents with significant heterogeneity in cardiac morphology and disease progression.
• A subset of patients experiences severe symptoms like dyspnea, angina, syncope, or sudden cardiac death.

Conclusions:

• Hypertrophic cardiomyopathy is a prevalent and heterogeneous cardiac disorder with a wide range of clinical outcomes.
• Understanding the variability in HCM presentation is crucial for patient management and risk stratification.
• Further research is needed to elucidate the mechanisms underlying HCM heterogeneity and improve therapeutic strategies.